LA16 (Tenofovir Disoproxil Fumarate 300 mg)
Pill with imprint LA16 is Blue, Elliptical/Oval and has been identified as Tenofovir Disoproxil Fumarate 300 mg. It is supplied by Laurus Labs Limited.
Tenofovir is used in the treatment of hepatitis b; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Tenofovir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LA16
Tenofovir Disoproxil Fumarate
- Imprint
- LA16
- Strength
- 300 mg
- Color
- Blue
- Size
- 17.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Laurus Labs Limited
- National Drug Code (NDC)
- 42385-0901
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
corn starch,
croscarmellose sodium,
magnesium stearate,
hypromellose 2910 (15 mPa.s),
titanium dioxide,
triacetin,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
Related Images for "LA16"
More about tenofovir
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (22)
- Drug images
- Compare alternatives
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
- Drug Information
- Tenofovir (Advanced Reading)
- Tenofovir Disoproxil Fumarate Tablets
- Tenofovir Disoproxil Fumarate Oral Powder
- Other brands
- Viread
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.